Performance evaluation of a POCT analyzer in relation to the results of routine conventional clinical laboratory methods in a nursing home. Cali. 2014
PDF (Español (España))

Keywords

health services for the aged
point-of-care testing
analytical chemistry techniques
instrumentation

How to Cite

Salcedo-Cifuentes, M., Gómez, F., Curcio, C.-L., Corchuelo, J., & Méndez, F. (2021). Performance evaluation of a POCT analyzer in relation to the results of routine conventional clinical laboratory methods in a nursing home. Cali. 2014. Médicas UIS, 34(2), 9–18. https://doi.org/10.18273/revmed.v34n2-2021001

Abstract

Introduction: Point-of-care testing (POCT) are clinical diagnostic tests carried out than laboratory analysts, outside of spaces specifically designed for clinical analysis, and they provide quick results that improve the timeliness of medical decision making. In Colombia there is no information on its use and performance in specific age groups such as those in nursing homes. Objective: To evaluate the performance of a POCT analyzer for lipid profile (CT, LDL-c, HDL-c, TG) and glycemia in relation to the results of routine conventional methods of the clinical laboratory in a nursing home. Materials and methods: Descriptive cross-sectional. 52 residents were taken to whom paired samples were applied. Glucose and lipid levels were determined. Samples collected by fingerstick were analyzed by POCT and venipuncture by conventional methods certified by the CDC in the laboratory. A standardized instrument was used to describe the desired characteristics of the POCT. Univariate and bivariate statistics were applied. The results issued by the clinical reference laboratory were compared with those of the POCT through the ICC. Results: The average age of the participants was 78, range 64-91 years. The POCT showed an aceptable performance compared to conventional clinical laboratory methods, especially TG and HDL-c. However, statistically significant differences were observed in the results of glycemia, CT and LDL-c delivered by the POCT compared to those of the clinical laboratory. Conclusions: POCT can be an important option for chronic disease screening and management in nursing homes. However, an organizational structure is necessary to ensure the quality of the POCT measurements. MÉD.UIS.2021;34(2): 9-18.

https://doi.org/10.18273/revmed.v34n2-2021001
PDF (Español (España))

References

Vashist SK. Point-of-Care Diagnostics: Recent Advances and Trends. Biosensors. 2017;7(4):62. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746785/.

Florkowski C, Don-Wauchope A, Gimenez N, Rodriguez-Capote K, Wils J, Zemlin A. Point-of-care testing (POCT) and evidence based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making?. Crit Rev Clin Lab Sc. 2017;54(7-8):471-494. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29169287/.

Larsson A, Greig-Pylypczuk R, Huisman A. The state of point-of care testing: a European perspective. Ups J Med Sci.2015;120(1):1-10. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25622619/.

Hyung-Doo P. Current Status of Clinical Application of Point of-Care Testing. Arch Pathol Lab Med. 2021;145(2):168–175. Disponible en: https://meridian.allenpress.com/aplm/article/145/2/168/445968/Current-Status-of-Clinical-Application-of-Point-of.

Florkowski C, Don-Wauchope A, Gimenez N, Rodriguez-Capote K, Wils J, Zemlin A. Point-of-care testing (POCT) and evidence based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making?. Crit Rev Clin Lab Sci. 2017;54(7-8):471-494.Disponible en: https://pubmed.ncbi.nlm.nih.gov/29169287/.

Oliver-Sáez P, Alonso-Díaz R, Lirón-Hernández J, Monzo-Inglés V, Navarro-Segarra X, et al. Guía sobre las pruebas de laboratorio en el lugar de asistencia al paciente (POCT). Rev Lab Clin. 2016;9(2):60-80. Disponible en: https://www.elsevier.es/es-revista-revista-del-laboratorio-clinico-282-articulo-guia-sobre-pruebas-laboratorio-el-S1888400816300058.

Holt H, Freedman D. Internal quality control in point of-care testing: where’s the evidence?. Ann Clin Biochem.2016;53(2):233-239.Disponible en: https://pubmed.ncbi.nlm.nih.gov/26486440/.

Shaw J. Practical challenges related to point of care testing. Pract Lab Med. 2016; 4:22-29. Disponible en: https://www.sciencedirect.com/science/article/pii/S2352551715300056.

Tirimacco R. Evolution of Point-of-Care Testing in Australia. Clin Biochem Rev. 2010; 31(3):75-80. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924125/.

St John A. The Evidence to Support Point-of-Care Testing. Clin Biochem Rev. 2010; 31(3):111–119. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924123/.

Gomez F, Corchuelo J, Curcio C-L, Calzada M-T, Mendez F. SABE Colombia: Survey on Health, Well-Being, and Aging in Colombia - Study Design and Protocol. Curr Gerontol Geriatr Res. 2016; 2016:1-7. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124445/.

Lehe JD, Sitoe NE, Tobaiwa O, Loquiha O, Quevedo J, Peter T, et al. Evaluating Operational Specifications of Point-of-Care Diagnostic Tests: A Standardized Scorecard. PLoS ONE. 2012; 7(10): 1-7. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485252/pdf/pone.0047459.pdf.

Myers G L, Cooper G, Winn C L, Smith J. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program: An Approach to Accurate and Precise Lipid Measurements. Clin Lab Med. 1989; 9(1): 105-135. Disponible en: https://pubmed.ncbi.nlm.nih.gov/2538292/.

Rosner B. Fundamentals of biostatistics. 4th ed. Harrisonburg, VA: Duxbury Press; 1995.

Klonoff DC. Point-of-Care Blood Glucose Meter Accuracy in the Hospital Setting. Diabetes Spectr. 2014; 27(3):174–179.

Whitehead SJ, Ford C, Gama R. The impact of different point-of-care testing lipid analysers on cardiovascular disease risk assessment, J Clin Pathol. 2014; 67(6):535-9.

Hermayer KL, Loftley AS, Reddy S, Narla SN, Epps NA, Zhu Y. Challenges of inpatient blood glucose monitoring: standards, methods, and devices to measure blood glucose. Curr Diab Rep. 2015; 15(3):10.

Whitehead SJ, Ford C, Gama R. A combined laboratory and field evaluation of the Cholestech LDX and CardioChek PA point-of-care testing lipid and glucose analyzers. Ann Clin Biochem. 2014; 51:54–67.

Ferreira CE, França CN, Correr CJ, Zucker ML, Andriolo A, Scartezini M. Clinical correlation between a point-of-care testing system and laboratory automation for lipid profile. Clinica Chimica Acta. 2015; 446 (6):263–6.

Deeg M. Variations in Lipid Values. LIPID TOPICS. 2006; 1 (3): 3 TB003.

Sohn AJ, Hickner JM, Alem F. Use of Point-of-Care Tests (POCTs) by US Primary Care Physicians. J Am Board Fam Med. 2016; 29 (3):371-6.

Mashamba-Thompson TP, Jama NA, Sartorius B, Drain PK, Thompson RM. Implementation of Point-of-Care Diagnostics in Rural Primary Healthcare Clinics in South Africa: Perspectives of Key Stakeholders. Diagnostics (Basel). 2017;7(1):3.

Khan A H, Shakeel Sh, Hooda K, Siddiqui K, Jafri L. Best practices in the implementation of a point of care testing program: Experience from a tertiary care hospital in a developing country. EJIFCC. 2019; 30 (3): 288-302.

Harris J, Laila O. AbdelWareth LO, Lari S, Callaghan K O, Anderson P, Mirza I. Setting Up a Point-of-Care Testing Service in a Greenfield, Quaternary Hospital: An Implementation Review. Arch Pathol Lab Med. 2018; 142 (10):1223-1232.

Quinn AD, Dixon D, Meenan BJ. Barriers to hospital-based clinical adoption of point-of-care testing (POCT): A systematic narrative review. Crit Rev Clin Lab Sci. 2016; 53(1):1-12.

Ceriotti F, Kaczmarek E, Guerra E, Mastrantonio F, Lucarelli F, Valgimigli F, et al. Comparative Performance Assessment of Point-of-Care Testing Devices for Measuring Glucose and Ketones at the Patient Bedside. J Diabetes Sci Technol. 2015;9(2):268-277.

Pratumvinit B, Charoenkoop N, Niwattisaiwong S, Kost GJ, Tientadakul P. The Effects of Temperature and Relative Humidity on Point-of-Care Glucose Measurements in Hospital Practice in a Tropical Clinical Setting. J Diabetes Sci Technol. 2016;10(5):1094-100. PubMed PMID: 26908568; PubMed Central PMCID: PMC5032940.

Lewandrowski K, Gregory K, Macmillan D. Assuring quality in point-of-care testing: evolution of technologies, informatics, and program management. Arch Pathol Lab Med. 2011;135(11):1405– 14. PubMed PMID: 22032566.

Clinical and Laboratory Standards Institute (CLSI). Point-of-Care In Vitro Diagnostic (IVD) Testing; Approved Guideline. Clinical and Laboratory Standards Institute document POCT04-A2 (ISBN 1-56238-618-2). 2nd ed. Wayne (PA): CLSI; 2010.

Lee-Lewandrowski E, Lewandrowski K. Implementing point-of-care testing to improve outcomes. J Hosp Admin. 2013;2(2):125– 32.

Leguizamón JE, González IA, Bernal LJ. Necesidades metrológicas en los laboratorios clínicos. Rev. Colomb. Quím. 2014;43(1):30-5.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2021 Médicas UIS

Downloads

Download data is not yet available.